Lancet

The most recent articles from: Lancet July 2021

Lancet · Jul 2021

Multicenter Study

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.

CARTITUDE-1 aimed to assess the safety and clinical activity of ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor T-cell therapy with two B-cell maturation antigen-targeting single-domain antibodies, in patients with relapsed or refractory multiple myeloma with poor prognosis. ⋯ Janssen Research & Development and Legend Biotech.

read on… mark as read…
Lancet · Jul 2021

Comment

Adjuvant metronomic chemotherapy for locoregionally advanced nasopharyngeal carcinoma.

no abstract available

expand abstract… or not…
Lancet · Jul 2021

Case Reports

Contrast-associated acute kidney injury in a patient with lower respiratory tract infection.

no abstract available

read on… or not…
Lancet · Jul 2021

Portrait or snapshot?

no abstract available

read on… or just mark as read…
Lancet · Jul 2021

FDA approval of dapagliflozin for chronic kidney disease: a remarkable achievement?

no abstract available

keep reading… mark as read…

1
2
…
5
6
7
8
9
10
11
12
13
…
37
38

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,706,642 articles already indexed!